Celcuity (CELC) Consolidated Net Income (2016 - 2025)
Celcuity (CELC) posted Consolidated Net Income of -$51.0 million for Q4 2025, down 16.37% on a QoQ basis from -$43.8 million in Q3 2025, and down 39.07% year-over-year from -$83.7 million in Q4 2024.
Celcuity (CELC) Consolidated Net Income (2016 - 2025) Analysis & Trends
Celcuity's Consolidated Net Income history runs 10 years deep, the most recent figure standing at -$51.0 million for Q4 2025.
- Quarterly Consolidated Net Income fell 39.07% year-over-year to -$51.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$177.0 million (down 58.39% YoY) and the FY2025 annual result came in at -$139.9 million, down 24.38% from the prior year.
- Consolidated Net Income was -$51.0 million for Q4 2025 at Celcuity, down from -$43.8 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at -$2.8 million in Q1 2021 and bottomed at -$51.0 million in Q4 2025.
- A 5-year average of -$21.1 million and a median of -$16.5 million in 2023 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2021 — Consolidated Net Income sank 1104.06% — and 2022, when it climbed 29.02%.
- Celcuity's Consolidated Net Income stood at -$6.8 million in 2021, then slumped by 71.49% to -$11.6 million in 2022, then plunged by 62.75% to -$18.8 million in 2023, then slumped by 94.46% to -$36.7 million in 2024, then slumped by 39.07% to -$51.0 million in 2025.
- Business Quant data shows CELC's Consolidated Net Income at -$51.0 million in Q4 2025, -$43.8 million in Q3 2025, and -$45.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | -50.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50.97 Mn |
| Sep 30, 2025 | -43.80 Mn |
| Jun 30, 2025 | -45.27 Mn |
| Mar 31, 2025 | -37.00 Mn |
| Dec 31, 2024 | -36.65 Mn |
| Sep 30, 2024 | -29.79 Mn |
| Jun 30, 2024 | -23.72 Mn |
| Mar 31, 2024 | -21.61 Mn |
| Dec 31, 2023 | -18.85 Mn |
| Sep 30, 2023 | -18.40 Mn |
| Jun 30, 2023 | -14.59 Mn |
| Mar 31, 2023 | -11.94 Mn |
| Dec 31, 2022 | -11.58 Mn |
| Sep 30, 2022 | -10.89 Mn |
| Jun 30, 2022 | -9.96 Mn |
| Mar 31, 2022 | -7.93 Mn |
| Dec 31, 2021 | -6.75 Mn |
| Sep 30, 2021 | -6.03 Mn |
| Jun 30, 2021 | -14.03 Mn |
| Mar 31, 2021 | -2.79 Mn |